ImmunoTX Summit
Date: February 6 - 7, 2017
Venue: Hard Rock Hotel San Diego, San Diego, CA, USA

15th Cytokines & Inflammation

9th Immunotherapeutics & Immunomonitoring

5th Immunogenicity & Immunotoxicity
GTCbio offers comprehensive sponsorship packages for all our meetings, including presentation opportunities, exhibit and booth space, as well as the event delegate list. All our packages can be customized to meet your company's budget. For information, please contact us.
GTCbio encourages attendees to showcase their research at the conference by presenting a poster. The top 2-3 submitted posters will also be selected to give short oral presentations as part of the meeting program. Abstracts will be accepted until December 6, 2016; slots fill up quickly so submit yours online ASAP!

Dear Colleague,

We invite you to GTCbio's ImmunoTX Summit, which takes place on February 6-7, 2017 in San Diego, CA. The summit will bring together our usual balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain a fresh perspective on the various topics below.

15th Cytokines & Inflammation
This conference has become an established meeting point for academic scientists, industry clinical developers, and government researchers to discuss complementary approaches in the field of cytokine biology. Some focused topics we will discuss include developments in the therapeutic application of cytokines and proposal of new targets, the complex relationship between the immune system and microbes in the homeostasis of mucosal tissues, novel means to modulate immune pathways to promote anti-tumor activity, and many more.

9th Immunotherapeutics & Immunomonitoring
Leading experts from the scientific and clinical arenas and industry will present novel findings and developments in the constantly-changing area of immunological assays and procedures. They will also discuss recent advances in immunotherapy as they relate to various immunotherapy modalities, specific cancers, cell subsets, animal models, and tumor microenvironment. Potential clinical feasibility and commercial potential of the newest data obtained from leading biomedical research laboratories will also be discussed.

5th Immunogenicity & Immunotoxicity
We will provide guests with a better understanding of the ongoing research for tools to mitigate risks associated with the immunogenicity of therapeutic proteins. Guests will get an up-to-date understanding of the mechanisms and consequences of protein aggregation and insights on how to prosecute state-of-the-art assessment of the clinical immunogenicity of therapeutic proteins.

We hope to see you there!

Best regards,

The 2017 Organizing Committee

What Past Delegates said:

"The GTC conference definitely provided a private, common, and friendly setting to exchange ideas and opinions with industry and academia leaders. Networking really happens at this conference with relevant and exciting topics. I left the GTC conference with fresh ideas and with new connections for future partnerships." - Mario Pulido, PhD Student, USC

"The topics covered in the 4th Immunotherapeutics and Immunomonitoring Conference were targeted and provided an excellent balance between clinical and basic research. Moreover, the intimate setting was an ideal environment to foster collaboration." - Fatema Legrand, Associate Director, Clinical Immunology, BN Immunotherapeutics

"The GTC Immunotherapeutics Summit was a great opportunity to meet industry and academic leaders. The networking opportunities were ideal for meaningful exchanges and setting up potential collaborations." - Yoav Peretz Ph.D., Principal Scientist, ImmuneCarta Services
journal of rheumatology

immunotx-summit Overview